Clinical Trials
27 trialsTOX-FRAIL
Ankara Etlik City Hospital
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
RenJi Hospital
OPTImaL
The Netherlands Cancer Institute
CD155 in Bladder Cancer
Fudan University
POROMS
Beijing Stomatological Hospital, Capital Medical University
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Mayo Clinic
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Peking Union Medical College Hospital
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy
Seoul National University Hospital
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
CETC
University of Jena
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Wake Forest University Health Sciences
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
Tang-Du Hospital
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Shanghai Zhongshan Hospital
Predictors of Recurrence for High Risk Endometrial Cancer Patients
Far Eastern Memorial Hospital
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Factors Predicting Recurrence in Rectal Cancer After Surgery
Université de Sousse
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Head & Neck Cancer Survivorship: Physical and Functional Status
Vanderbilt University
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
University of Wisconsin, Madison
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
National Cancer Institute (NCI)
S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
SWOG Cancer Research Network